(Q35755466)

10 August 2017

1 reference

title

Preclinical models of human peripheral arterial occlusive disease: implications for investigation of therapeutic agents (English)

1 reference

10 August 2017

4

Brian H Annex

1 reference

10 August 2017

Richard E Waters

1

1 reference

10 August 2017

Ronald L Terjung

series ordinal

2

1 reference

10 August 2017

Kevin G Peters

series ordinal

3

1 reference

10 August 2017

language of work or name

English

0 references

publication date

23 April 2004

1 reference

Journal of Applied Physiology

10 August 2017

published in

1 reference

10 August 2017

volume

97

1 reference

10 August 2017

issue

2

1 reference

10 August 2017

page(s)

773-780

1 reference

A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00107.2004

An investigation of arterial insufficiency in rat hindlimb. A combined 31P-n.m.r. and bloodflow study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00107.2004

The prevalence of peripheral arterial disease in a defined population

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00107.2004

Alterations in endothelial cell proliferation and apoptosis contribute to vascular remodeling following hind-limb ischemia in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00107.2004

Hyperhomocysteinemia impairs angiogenesis in response to hindlimb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00107.2004

Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00107.2004

Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00107.2004

Adenovirus-mediated VEGF(121) gene transfer stimulates angiogenesis in normoperfused skeletal muscle and preserves tissue perfusion after induction of ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00107.2004

A model of persistent partial hindlimb ischemia in the rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00107.2004

Medical treatment of peripheral arterial disease and claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00107.2004

Peripheral arterial disease detection, awareness, and treatment in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00107.2004

An experimental model of ischemia in rabbit hindlimb

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00107.2004

Translational physiology: porcine models of human coronary artery disease: implications for preclinical trials of therapeutic angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00107.2004

Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00107.2004

Design of the therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (TRAFFIC) trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00107.2004

Collateral circulation in the limb

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00107.2004

Angiogenic gene therapy for experimental critical limb ischemia: acceleration of limb loss by overexpression of vascular endothelial growth factor 165 but not of fibroblast growth factor-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00107.2004

Nitric oxide synthase modulates angiogenesis in response to tissue ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00107.2004

Vascular endothelial growth factor response in porcine coronary and peripheral arteries using nonsurgical occlusion model, local delivery, and liposome-mediated gene transfer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00107.2004

A persistent hindlimb ischemia model in the rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00107.2004

Conservative management of intermittent claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00107.2004

Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermitt

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00107.2004

Current medical therapies for patients with peripheral arterial disease: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00107.2004

Age-dependent impairment of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00107.2004

Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00107.2004

Left subclavian flap aortoplasty for coarctation of the aorta: effects on forearm vascular function and growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00107.2004

Hypercholesterolemia attenuates angiogenesis but does not preclude augmentation by angiogenic cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00107.2004

Vascular endothelial growth factor augments muscle blood flow and function in a rabbit model of chronic hindlimb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00107.2004

Modulation of growth factor action: implications for the treatment of cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00107.2004

Prior exercise training produces NO-dependent increases in collateral blood flow after acute arterial occlusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00107.2004

Angiotensin-converting enzyme inhibition increases collateral-dependent muscle blood flow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00107.2004

10.1152/JAPPLPHYSIOL.00107.2004

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference